Allegheny IBD Rating Rises From 80 to 97

On Friday, ATI got an upgrade for its IBD SmartSelect Composite Rating from 80 to 97.

ATI Stock Earns IBD Stock Rating Upgrade

ATI shares rose after KeyBanc analyst Philip Gibbs upgraded the stock to Overweight with a $55 price target. He expects strong operational performance and modest engine aftermarket growth, despite potential tariff risks and a slowdown in airframe titanium sales. The 2025 earnings estimate remains unchanged, with no significant impact from recent labor negotiations. The company is well-positioned for growth in the aerospace and defense sectors. ATI shares increased by 10.63% to $50.46.

ATI Upgrade: Analyst Weighs Strong Aftermarket, OE Ramp Against Tariff Risks And Airframe Slowdown

Soros Fund Management LLC increased its stake in ATI Inc. (NYSE:ATI) by 98.3% in Q4, owning 391,501 shares valued at $21.5 million. Other investors also adjusted their holdings, with notable increases from Smartleaf Asset Management and Blue Trust Inc. Analysts have raised price targets for ATI, with a consensus rating of "Moderate Buy" and an average target of $73.29. ATI reported Q4 earnings of $0.79 per share, exceeding estimates, with revenue of $1.17 billion, a 10.2% increase year-over-year.

Allegheny IBD Rating Rises From 80 to 97

Summary

Impact Analysis